F.D.A. Clears Cheaper Version of Johnson & Johnson Biologic by THE ASSOCIATED PRESS

By THE ASSOCIATED PRESS

Federal officials have approved a cheaper version of Johnson & Johnson’s blockbuster drug Remicade, a biotech medicine for inflammatory diseases.

Published: April 6, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1S0Ja1M

from WordPress http://ift.tt/205LB3c
via Hadi Aboukhater